AstraZeneca to Cut 2,300 Jobs

Thu, 03/21/2013 - 7:51am

LONDON (AP) — Struggling drug company AstraZeneca PLC says it will cut some 2,300 jobs worldwide as part of a restructuring plan.

The company said Thursday the cuts are in addition to a previously announced program cutting 1,600 positions related to research and development announced March 18 and the elimination of 1,150 positions announced last year.

A company statement indicates the elimination of these positions will result in a one-time $2.3 billion restructuring charge.

The company anticipates the cuts will produce benefits of about $800 million per year by 2016.

New CEO Pacal Soriot said the company's goal is to be a global firm with a "focused portfolio in core therapy areas."

The company's finances have been hurt as generic competition has damaged sales.




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.